A growing library of original, evidence-labeled articles written from published research. Every piece is dated to when the science came out, links its sources, and is information — not medical advice.
Where the science of curing Type 1 diabetes actually stands: islet and stem-cell therapies, beta-cell regeneration, immunotherapies, and disease-modifying trials, in plain language.
BrowseWhat science understands about why Type 1 diabetes happens: autoimmunity, genetics, environmental and viral triggers, and the gaps researchers are still working to close.
BrowseHow Type 1 diabetes is found and staged today: autoantibody screening, early-stage detection, presentation, and what new diagnostic research means for families.
BrowseEvidence-labeled nutrition research for living with Type 1 diabetes: carbohydrate strategies, glycemic response, and what studies do and do not show. Information, not medical advice.
BrowseResearch on the daily levers around Type 1 diabetes: exercise, sleep, stress, and routines, with honest evidence labels on what is well supported versus emerging.
BrowseThe lived reality of Type 1 diabetes: management technology, mental health, quality of life, and family support, grounded in current research.
BrowseA recent study published in PLOS Medicine investigates the effectiveness and safety of statin therapy for primary cardiovascular disease prevention in older adults with type 2 diabetes.
Read article
Advances in diabetes technologies are transforming the management of type 1 diabetes. But what's next for automated insulin delivery systems?
A recent study published in BMC Endocrine Disorders explores the long-term impact of virtual care on young adults with type 1 diabetes, showing promising results for glycemic control and quality of life.
A recent study analyzed real-world data from over 176,000 Type 1 diabetes users to identify settings and behaviors associated with achieving optimal glycemic outcomes with the Omnipod 5 Automated Insulin Delivery System.
A new tool helps identify children with type 1 diabetes at higher risk for diabetic ketoacidosis (DKA), a potentially life-threatening complication.
A new study finds that using automated insulin delivery systems can lead to better blood sugar control in young children with type 1 diabetes.
A recent study found that temporarily suspending prior authorization requirements for diabetes technology improved access and glycemic control in an underserved population.
A recent study found that using continuous glucose monitors (CGMs) may reduce mortality rates among older adults with Type 1 diabetes.
Researchers analyzed data from a trial of the Resilient, Empowered, Active Living-Telehealth (REAL-T) intervention to identify factors associated with improved glucose control and quality of life.
A recent review of 23 studies shows that gamified interventions can improve glycemic control and self-management in kids with T1D.
A new study examines the use of automated insulin delivery systems in pregnant women with type 1 diabetes, finding that glucose control remains stable during labor and delivery.
A new study reveals a strong link between eHealth literacy and self-care in adolescents with type 1 diabetes.
New research reveals a strong link between continuous glucose monitoring metrics and the risk of severe hypoglycemia in people with Type 1 diabetes.
Type1Cure is an information and intelligence hub, not a medical advice service. Articles summarize published research and link their sources. Always talk to your own care team before changing anything about your Type 1 diabetes management.